INVO Fertility, Inc. (IVF)
2025-06-30 | 2025-03-31 | |||
|---|---|---|---|---|
| Total revenue | 1,863,654 | 1,637,185 | ||
| Impairment loss | - | 14,645,069 | ||
| Cost of revenue | - | 1,044,929 | ||
| Selling, general and administrative expenses | 2,193,049 | 2,554,474 | ||
| Research and development expenses | - | 265,663 | ||
| Depreciation and amortization | 169,737 | 234,462 | ||
| Impairment loss | 1,397,353 | - | ||
| Cost of revenue | 1,093,603 | - | ||
| Total operating expenses | 4,853,742 | 18,744,597 | ||
| Loss from operations | -2,990,088 | -17,107,412 | ||
| Interest expense | 221,325 | 311,270 | ||
| Gain (loss) from equity method joint ventures | -19,911 | 15,096 | ||
| Loss on debt extinguishment | -692,270 | - | ||
| Gain on lease termination | - | - | ||
| (gain) loss on disposal of fixed assets | - | - | ||
| Gain on settlement (note 17) | 714,500 | - | ||
| Total other income (expense) | -219,006 | -296,174 | ||
| Net loss from continuing operations before income taxes | -3,209,094 | -17,403,586 | ||
| Income taxes | - | - | ||
| Net loss from continuing operations | -3,209,094 | - | ||
| Loss on discontinued operations of nti | -541,247 | - | ||
| Loss on disposal of nti | -1,534,517 | - | ||
| Net loss | -5,284,858 | -17,403,586 | ||
| Basic | -13.3 | -12.53 | ||
| Basic | 397,440 | 1,389,141 | ||
| Diluted | -13.3 | -12.53 | ||
| Diluted | 397,440 | 1,389,141 | ||